Re-dosing study of outlier in BA/BE studies [Design Issues]

posted by harrypotter_1234567 – 2010-11-23 13:53 (5696 d 03:21 ago) – Posting: # 6195
Views: 6,919

Hi,
suppose if i conduct two way crossover BA/BE study in 60 subjects, out of this 60 subjects, if 1 subject is considered outlier as per analytical data.
How can we plan redosing study in 10 subjects including anamolus?

If anamolous subject gets the same concentration data as same as previous study, what should be done with study results?

Or is there any provision for outlier in any guideline?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
375 visitors (0 registered, 375 guests [including 14 identified bots]).
Forum time: 18:15 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5